This Phase II, randomized, double-blind, two arm, outpatient, multicenter study is designed to evaluate the safety and tolerance of ZDV monotherapy vs. d4T monotherapy. Preliminary HIV activity data also will be collected.
Showing the most recent 10 out of 463 publications